- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02343055
COPE With COPD Trial
Collaborative Self-Management Patient Education Will Improve Health Outcomes in COPD
The overall objective of this study is to evaluate a collaborative self-management intervention in patients with moderate to severe COPD in a primary care population. To achieve this objective the investigators developed a diagnostic and treatment pathway for the management of COPD in primary care that is based on national guidelines and focused on patient self-management.
.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Ontario
-
Amherstburg, Ontario, Canada, N9V 0B4
- Amherstburg FHT
-
Chatham, Ontario, Canada, N7L 5K5
- Chatham-Kent FHT
-
Harrow, Ontario, Canada, NOR 1G0
- Harrow FHT
-
Leamington, Ontario, Canada, N8H 1N8
- Leamington FHT
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Current or Ex-smokers
- 40 years of age or over
- Minimum 10 pack year smoking history
- Post-bronchodilator FEV1 of 70% or less (4 puffs of Salbutamol) and Forced Expiratory Volume at 1sec to Forced Vital Capacity (FEV1/FVC) ratio 70% or less
- A history of two exacerbations (involving treatment and/or visit to a health care practitioner) in the past 3 years OR 1 exacerbation in the past year
- Provides informed consent
Exclusion Criteria:
- COPD exacerbation in the past 4 weeks
- Diagnosis of asthma prior to the age of 40 years
- Co-existing illness that could interfere with study results (ie. Congestive Heart Failure with exacerbation of symptoms)
- Scheduled for COPD rehabilitation
- A terminal illness
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Case Management and Self-Management Education
A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician.
Specific elements of evidence-based management are targetted for intervention.
Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months.
Telephone follow up will occur at a minimum at 6 and 9 months.
|
A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician.
Specific elements of evidence-based management are targetted for intervention.
Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months.
Telephone follow up will occur at a minimum at 6 and 9 months.
|
Comparateur placebo: Usual Care
A Certified Respiratory Educator (CRE) will meet with subjects to obtain a detailed COPD history and do a breathing test.
Subjects will receive COPD care as usually provided by their physician.
|
A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician.
Specific elements of evidence-based management are targetted for intervention.
Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months.
Telephone follow up will occur at a minimum at 6 and 9 months.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
COPD Assessment Test (CAT)
Délai: 1 Year
|
COPD related quality of life measure in primary care.
|
1 Year
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Health Care Utilization for Emergency Department visits proportion and rate per year
Délai: 1 year
|
The proportion of subjects that utilized the Emergency for a COPD exacerbation
|
1 year
|
Health Care Utilization for Hospital Admission proportion and rate per year
Délai: 1 year
|
The proportion of subjects that were admitted to hospital for a COPD exacerbation An exacerbation is defined as an increase in or the onset of more than one respiratory symptom (cough, sputum, sputum purulence, wheezing, or dyspnea) lasting 3 days or more and requiring treatment with an antibiotic or a systemic corticosteroid.
Respiratory status had to return to baseline for at least 72 hours before another exacerbation would be counted.
|
1 year
|
Severe Exacerbation proportion and rate per year
Délai: 1 year
|
The proportion of subjects experiencing one or more exacerbations in the study interval.
An exacerbation diary will be completed for each event.
|
1 year
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Quality of Life
Délai: 1 year
|
Improvement of Quality of Life using the CAT score(COPD Assessment Test)
|
1 year
|
Improvement in Knowledge of COPD and confidence in self-management
Délai: 1 year
|
Improvement in Bristol COPD Knowledge Questionnaire and patient self report
|
1 year
|
Process of Care
Délai: 1 year
|
Process of care: have written action plan, used action plan, advised to quit smoking, offered pharmacologic help with quitting, quit smoking, current packs/day, diagnosis confirmed by spirometry, vaccination rates, instructed on inhaler technique, vaccination rates
|
1 year
|
Dyspnea Improvement
Délai: 1 year
|
Change in dyspnea using the modified MRC questionnaire - Medical Research Council (MRC).
|
1 year
|
Disease control
Délai: 1 year
|
Disease control using the Clinical COPD questionnaire (CCQ)
|
1 year
|
Symptom Profile
Délai: 1 year
|
Change in Symptom profile (cough, wheeze, sputum production)
|
1 year
|
Forced Expiratory Volume at 1sec (FEV1) % predicted
Délai: 1 year
|
FEV1
|
1 year
|
Proportion of Patients on therapy appropriate to their stage of disease
Délai: 1 year
|
Evaluate medication prescribed related to stage of disease
|
1 year
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Christopher Licskai, Lawson Health Research Institution
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 00000941
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .